QUIDELORTHO

quidelortho-logo

Quidel Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of point-of-care (POC) diagnostic solutions for infectious diseases, and reproductive and women's health. It provides POC and other diagnostic tests under the QuickVue, QuickVue+, QuickVue Advance, Metra, Quidel, and MicroVue brand names. The company offers products for infectious diseases, such as Influenza, Group A Strep, and Respiratory Syncitial Virus; and for reproductive and women's h... ealth, including pregnancy, Chlamydia, Bacterial Vaginosis, and Bone Health. It also offers Immunoassay fecal occult blood test used to detect the presence of blood in stool specimens; and Helicobacter pylori test, a serological test to measure antibodies circulating in the blood caused by the immune response to the H. pylori bacterium. In addition, the company provides veterinary products; and clinical laboratory and research tests that are used in the measurement of circulating immune complexes, complement deficiencies, and complement activation. It sells its products to professionals for use in physician offices, hospitals, clinical laboratories, retail clinics, and wellness screening centers through a network of national and regional distributors, and a direct sales force in the United States, as well as through distributor arrangements primarily in Japan, Europe, and the Middle East. The company has an agreement with BioHelix Corporation for the development and commercialization of in vitro molecular diagnostic tests utilizing isothermal amplification technology. Quidel Corporation was founded in 1979 and is based in San Diego, California.

#SimilarOrganizations #People #Financial #Website #More

QUIDELORTHO

Industry:
Biotechnology Health Care Manufacturing Pharmaceutical

Founded:
1979-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.quidel.com

Total Employee:
501+

Status:
Active

Contact:
8585526432

Email Addresses:
[email protected]

Total Funding:
0

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome Wordpress Plugins


Similar Organizations

epivax-logo

EpiVax

EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.

idera-pharmaceuticals-logo

Idera Pharmaceuticals

Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.


Current Advisors List

mary-polan_image

Mary Polan Board of Directors @ QuidelOrtho
Board_member

Current Employees Featured

jack-schuler_image

Jack Schuler
Jack Schuler Director @ QuidelOrtho
Director

karen-gibson_image

Karen Gibson
Karen Gibson SVP, Business Transformation @ QuidelOrtho
SVP, Business Transformation

robert-c-meck_image

Robert C. Meck
Robert C. Meck Senior Director of Advanced Engineering @ QuidelOrtho
Senior Director of Advanced Engineering
2021-11-01

not_available_image

Douglas C. Bryant
Douglas C. Bryant President & CEO @ QuidelOrtho
President & CEO

frank-pokrop_image

Frank Pokrop
Frank Pokrop Director of Regulatory Affairs @ QuidelOrtho
Director of Regulatory Affairs

Founder


david-katz_image

David Katz

scott-glenn_image

Scott Glenn

Stock Details


Company's stock symbol is NASDAQ:QDEL

Acquisitions List

Date Company Article Price
2021-12-23 Ortho-Clinical Diagnostics Ortho-Clinical Diagnostics acquired by QuidelOrtho 6 B USD
2017-07-17 Alere - Triage Assets Alere - Triage Assets acquired by QuidelOrtho 400 M USD
2017-05-16 RPS Diagnostics - InflammaDry and AdenoPlus diagnostic businesses RPS Diagnostics - InflammaDry and AdenoPlus diagnostic businesses acquired by QuidelOrtho 14 M USD
2016-03-18 Immutopics Immutopics acquired by QuidelOrtho 5.5 M USD
2013-10-24 AnDiaTec AnDiaTec acquired by QuidelOrtho 7.3 M USD
2013-05-07 Biohelix Biohelix acquired by QuidelOrtho 10 M USD
2010-01-12 Diagnostic Hybrids Diagnostic Hybrids acquired by QuidelOrtho N/A
2000-12-01 Litmus Concepts Litmus Concepts acquired by QuidelOrtho 17.3 M USD
1999-06-07 Metra Biosystems Metra Biosystems acquired by QuidelOrtho 22.9 M USD
1998-11-01 Dade Behring - POC Urine Test Strip Business Dade Behring - POC Urine Test Strip Business acquired by QuidelOrtho N/A

Investors List

biomedical-advanced-research-and-development-authority-barda_image

Biomedical Advanced Research and Development Authority (BARDA)

Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - QuidelOrtho

Official Site Inspections

http://www.quidel.com Semrush global rank: 310.12 K Semrush visits lastest month: 202.56 K

  • Host name: 151.101.67.10
  • IP address: 151.101.67.10
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "QuidelOrtho"

English | QuidelOrtho

We invite you to connect with us and explore how our diagnostic portfolio can make a difference in your healthcare setting. Together, we can work toward a healthier future by leveraging advanced diagnostics to improve patient care, safety and treatment decisions.See details»

Our Company | QuidelOrtho

As an IVD leader, our focus on innovation, problem-solving and customer-centricity, along with our commitment to quality and global collaboration, uniquely position us to shape the future of diagnostics.See details»

QuidelOrtho - Crunchbase Company Profile & Funding

Quidel Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of point-of-care (POC)See details»

Leadership | QuidelOrtho

Brian Blaser sets the long-term vision and strategy for QuidelOrtho. He has more than 25 years of senior leadership experience in the in vitro diagnostics industry, including 15 years with Abbott Laboratories overseeing its global diagnostics organization for โ€ฆSee details»

QuidelOrtho - Wikipedia

QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide. [3] On May 8, 2020 the U.S. Food and Drug Administration (FDA) issued to Quidel the first emergency use authorization (EUA) for a COVID-19 rapid antigen test, a new category of tests for use in the ongoing pandemic. These diagnostic tests quickly detect โ€ฆSee details»

Quidel Corp Company Profile - Quidel Corp Overview - GlobalData

Up-to-date Quidel Corp company overview including funding information, company profile, key statistics, peer comparison and more.See details»

Quidel Company Profile -Sales, Contacts, Competitors โ€“ Buzzfile

Quidel is located in San Diego, California. This organization primarily operates in the Pregnancy Test Kits business / industry within the Chemicals and Allied Products sector. This organization has been operating for approximately 3 years. Quidel is estimated to generate $1.7 billion in annual revenues, and employs approximately 99 people at this headquarters location and โ€ฆSee details»

Quidel - Devex

Quidel Corporation (Nasdaq: QDEL) is a California-based leading diagnostic healthcare manufacturer serving to enhance the health and well-being of people around the globe through the development ...See details»

QuidelOrtho Corporation (QDEL): history, ownership, mission, how โ€ฆ

Mergers and Combinations: The merger of Quidel Corporation and Ortho Clinical Diagnostics in 2022 to form QuidelOrtho was a transformative moment, creating a more diversified and robust company with a broader range of diagnostic solutions.See details»

QuidelOrtho Corporation - Governance

At QuidelOrtho, we are committed to conducting our business in accordance with all applicable laws, rules, and regulations, and the highest ethical standards. This section includes documents regarding the Company's corporate governance practices, evidencing the Company's commitment to sound principles of corporate governance.See details»

Quidel Company Profile - Office Locations, Competitors ... - Craft

Quidel $1.7 b in annual revenue in FY 2021. See insights on Quidel including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

QuidelOrtho Corporation โ€“ Point of Care Testing Innovators

QuidelOrtho Corporation unites the power of Quidel Corporation and Ortho Clinical Diagnostics behind a shared mission of developing and manufacturing innovative technologies that raise the performance of diagnostic testing and create better patient โ€ฆSee details»

QuidelOrtho Corp (QDEL) Q1 2025 Earnings Call Highlights: Strong โ€ฆ

10 hours ago QuidelOrtho Corp (QDEL) reports robust growth in labs and molecular diagnostics, while navigating challenges from declining COVID-related revenues and tariff impacts.See details»

QuidelOrtho. Information about the issuer. (LEI โ€ฆ

QuidelOrtho Corporation (formerly Quidel Corporation) is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions primarily include applications in infectious diseases, โ€ฆSee details»

Quidel | Ohio Life Sciences

Quidel Quidel Corporation (formerly Diagnostic HYBRIDS, Inc.) is a manufacturer of diagnostic healthcare solutions serving to enhance the health and well-being of people around the globe through the development of diagnostic solutions that can lead to improved patient outcomes and provide economic benefits to the healthcare system. Quidelโ€™s core competencies and โ€ฆSee details»

MyQuidel

MyQuidel allows you to download and install the latest Software Updates, Assay and testing capabilities for your Quidel Instruments. In addition users can report software updates and manage instruments online.See details»

Quidel - MDDI Online

Jan 2, 2022 Quidel made a huge investment to strengthen its prowess in the in vitro diagnostics market. The San Diego, CA-based company said it has signed an agreement to acquire Ortho Clinical Diagnostics Holdings for $6 billion. The deal is expected to close in the first half of fiscal year 2022. โ€œThe combination with Ortho will help solidify Quidel as a leader in the diagnostics โ€ฆSee details»

Medical Countermeasures

Quidelโ€™s research and development engine is also developing a continuum of diagnostic solutions from advanced immunoassay to molecular diagnostic tests to further improve the quality of healthcare in physiciansโ€™ offices and hospital and reference laboratories.See details»

Quidel Announces Stockholder Approval Of Ortho ... - QuidelOrtho

May 16, 2022 QuidelOrtho Corporation announced that the previously announced acquisition of Ortho Clinical Diagnostics Holdings plc (โ€œOrthoโ€) by Quidel and subsequent business combination were approved by Quidelโ€™s stockholders at Quidelโ€™s Special Meeting on May 16, 2022.See details»

Education From Quidel

Quidel is making a commitment to medical and laboratory professionals by providing accredited online education on topics directly related to their needs. The educational topics will focus on the disease states and the diagnostic solutions Quidel provides in the endeavor to improve patient outcomes while providing economic benefits to the ...See details»

linkstock.net © 2022. All rights reserved